Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer

NCT05163223 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty in recruiting patients

Conditions

Breast Cancer

Interventions

BIOLOGICAL: AST-301(pNGVL3-hICD)
DRUG: rhuGM-CSF
DRUG: Placebo
DRUG: Pembrolizumab
DRUG: Capecitabine

Sponsor

Aston Sci. Inc.